股票代码：600195 股票简称：中牧股份 公告编号：临 2025-032 中牧实业股份有限公司 重要内容提示： 兰州市城关区人民政府决定对中牧实业股份有限公司（以下简称"公 司"）的分支机构中牧实业股份有限公司兰州生物药厂（以下简称"中牧股份兰 州厂"）和公司全资子公司兰州中牧药械科技有限公司（以下简称"兰州中牧"） 所属位于兰州市城关区盐场路 2 号范围内国有土地、地上建（构）筑物和设备实 施征收，由兰州市城关区住房和城乡建设局组织实施，并委托兰州市城关区人民 政府盐场路街道办事处具体实施补偿安置工作，负责与公司签订征收补偿协议。 上述资产为中牧股份兰州厂和兰州中牧原厂区的土地、房产和生产设备，资产均 属于闲置状态。经甘肃方家房地产资产评估有限公司对以上资产进行评估，本次 征收的土地、地上建（构）筑物和设备涉及金额为 22,897.82 万元。 本次交易不构成关联交易和重大资产重组。 公司 2025 年 9 月 28 日召开第九届董事会 2025 年第十二次临时会议审议 通过《关于政府征收公司及全资子公司部分闲置资产的议案》，具体内容详见公 司于 2025 年 9 月 29 日披露的《中牧实业股份有限公司 ...

股票代码：600195 股票简称：中牧股份 编号：临 2025-031 中牧实业股份有限公司关于 修订《公司章程》及其附件并取消监事会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏， 并对其内容的真实性、准确性和完整性承担法律责任。 根据《中华人民共和国证券法（2019 年修订）》《中华人民共和国公司法（2023 年修订）》 《上市公司章程指引（2025 年修订）》等法律法规及规范性文件的要求，结合中牧实业股份有 限公司（以下简称"公司"）实际情况，将对《中牧实业股份有限公司章程》（以下简称《公司 章程》）及其附件中原《中牧实业股份有限公司股东大会议事规则》和《中牧实业股份有限公 司董事会议事规则》的部分条款进行修订。 2025 年 10 月 27 日，公司召开第九届董事会第四次会议审议通过《关于修订<公司章程> 及其附件并取消监事会的议案》，同意对《公司章程》及其附件的修订并取消监事会，由公司 董事会审计委员会行使原监事会职权。《中牧实业股份有限公司监事会议事规则》相应废止， 公司各项规章制度中涉及公司监事会、监事的规定不再适用，监事会成员将继续履职至公司股 东会审议 ...

股票代码：600195 股票简称：中牧股份 编号：临 2025-033 中牧实业股份有限公司 关于召开2025年第二次临时股东会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、 召开会议的基本情况 网络投票系统：上海证券交易所股东大会网络投票系统 网络投票起止时间：自2025 年 11 月 13 日 至2025 年 11 月 13 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 东会召开当日的交易时间段，即 9:15-9:25,9:30-11:30，13:00-15:00；通过互 股东会召开日期：2025年11月13日 本次股东会采用的网络投票系统：上海证券交易所股东大会网络投票系 统 (一) 股东会类型和届次 2025年第二次临时股东会 (二) 股东会召集人：董事会 (三) 投票方式：本次股东会所采用的表决方式是现场投票和网络投票相结合 的方式 (四) 现场会议召开的日期、时间和地点 召开的日期时间：2025 年 11 月 13 日 13 点 30 分 召开地点：北京市丰台 ...

股票代码：600195 股票简称：中牧股份 编号：临 2025-030 中牧实业股份有限公司 第九届董事会第四次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 中牧实业股份有限公司（以下简称"公司"或"中牧股份"）第九届董事会第 四次会议通知于 2025 年 10 月 17 日通过公司电子办公系统、电子邮件等形式发出， 会议于 2025 年 10 月 27 日在北京市丰台区总部基地八区 16 号楼 801 会议室以现场 结合视频方式召开，会议应到董事 7 名，实到董事 7 名。公司监事、高管人员列席 本次会议。会议由董事长吴冬荀先生主持，符合《公司法》《公司章程》的规定。 经与会董事审议，会议表决通过如下议案： 一、关于修订《公司章程》及其附件并取消监事会的议案 表决结果：7 票同意，0 票反对，0 票弃权。 同意对《中牧实业股份有限公司章程》及其附件中原《中牧实业股份有限公司 股东大会议事规则》和《中牧实业股份有限公司董事会议事规则》的部分条款进行 修订。 同意不再设置监事会，由公司董事会审计委员会行使原监事会 ...

Financial Performance - The company's revenue for the third quarter was CNY 1,649,715,696.47, a decrease of 2.90% compared to the same period last year[6] - Total profit for the quarter reached CNY 146,206,239.16, an increase of 323.86% year-on-year[6] - Net profit attributable to shareholders was CNY 143,593,934.33, reflecting a significant increase of 655.84% compared to the previous year[6] - The basic earnings per share for the quarter was CNY 0.1406, up 655.91% year-on-year[7] - The net profit excluding non-recurring gains and losses for the quarter was CNY 30,691,894.87, an increase of 57.34% year-on-year[6] - Total operating revenue for the first three quarters of 2025 reached ¥4,442,327,149.20, an increase of 6.3% compared to ¥4,178,404,928.63 in the same period of 2024[21] - Net profit for the first three quarters of 2025 was ¥230,257,589.02, significantly higher than ¥79,240,553.89 in 2024, marking an increase of 190.5%[22] - Earnings per share for the first three quarters of 2025 were ¥0.2207, compared to ¥0.0801 in the same period of 2024, representing a growth of 175.3%[23] - The company reported a total comprehensive income of ¥237,669,643.82 for the first three quarters of 2025, compared to ¥82,005,458.65 in 2024, showing a growth of 189.0%[23] Assets and Liabilities - The total assets of the company increased by 5.38% to CNY 9,320,058,769.33 compared to the end of the previous year[7] - Total current assets as of September 30, 2025, amount to RMB 4,098,609,622.27, an increase from RMB 3,520,322,605.70 at the end of 2024[17] - Total assets as of September 30, 2025, are RMB 9,320,058,769.33, compared to RMB 8,843,999,066.31 at the end of 2024[18] - Total liabilities as of September 30, 2025, are RMB 2,589,190,005.64, up from RMB 2,291,500,830.24 at the end of 2024[18] - Total liabilities increased to ¥2,633,723,351.79 in 2025 from ¥2,344,551,495.56 in 2024, reflecting a rise of 12.3%[19] - Total equity attributable to shareholders reached ¥5,717,341,909.44 in 2025, up from ¥5,505,042,539.52 in 2024, an increase of 3.8%[19] Cash Flow - Cash flow from operating activities for the first three quarters of 2025 was ¥42,994,163.24, a turnaround from a negative cash flow of ¥311,007,746.02 in 2024[25] - The net cash flow from financing activities was 204,242,810.70, a significant improvement from -239,236,006.80 in the previous period[26] - The total cash and cash equivalents at the end of the period were 906,059,806.05, down from 1,486,975,724.40, representing a decrease of approximately 39%[26] - The cash outflow for investment activities amounted to 397,932,691.45, compared to 345,073,746.65 in the previous period, indicating an increase of about 15.3%[26] - The cash paid for debt repayment was 444,796,336.87, a decrease from 1,072,490,381.76, showing a reduction of approximately 58.6%[26] - The cash paid for dividends and interest was 72,763,596.24, down from 162,270,157.43, indicating a decrease of about 55.2%[26] - The total cash outflow from financing activities was 517,715,933.11, down from 1,234,760,539.19, indicating a decrease of about 58%[26] Shareholder Information - Total number of common shareholders at the end of the reporting period is 36,856[14] - The largest shareholder, China Animal Husbandry Group Co., Ltd., holds 504,094,163 shares, accounting for 49.37% of total shares[14] - The company has no significant changes in the top 10 shareholders or their shareholding status[15] - The company has not engaged in any share lending or borrowing activities during the reporting period[15] Other Financial Metrics - Investment income rose by 63.88%, primarily due to increased net profit from a subsidiary[11] - The company reported a 198.68% increase in asset disposal income, attributed to higher fixed asset disposals compared to the previous year[11] - The weighted average return on equity for the quarter was 2.58%, an increase of 2.29 percentage points year-on-year[7] - The company experienced a 32.89% increase in accounts receivable, mainly due to increased receivables from strategic customers[11] - The company reported a significant increase in accounts receivable, rising to RMB 1,457,604,019.22 from RMB 1,096,819,017.67[17] - Research and development expenses for the first three quarters of 2025 amounted to ¥98,382,588.92, compared to ¥92,602,407.24 in 2024, indicating an increase of 6.2%[22] Future Outlook - The company plans to implement new accounting standards starting in 2025, which may affect the financial statements[26]

Group 1 - The horse racing concept sector declined by 1.06%, ranking among the top losers in the market, with major declines seen in companies like Zhujiang Piano and Zhongti Industry [1][2] - Among the horse racing concept stocks, Zhujiang Piano hit the daily limit down, while Zhongti Industry and Xinhua Dou also experienced significant declines [1][2] - Conversely, a few stocks in the sector saw gains, with *ST Zhengping, Zhongmu Co., and Hainan Rubber increasing by 5.03%, 0.41%, and 0.37% respectively [1][2] Group 2 - The horse racing concept sector experienced a net outflow of 0.38 billion yuan in capital today, with Xinhua Dou leading the outflow at 17.30 million yuan [2] - Other companies with significant capital outflows included Zhujiang Piano, Luoniushan, and Zhongti Industry, with outflows of 15.08 million yuan, 13.01 million yuan, and 12.06 million yuan respectively [2] - In contrast, Hainan Rubber, *ST Zhengping, and Zhongmu Co. saw net inflows of 14.36 million yuan, 4.76 million yuan, and 0.38 million yuan respectively [2]

Core Viewpoint - The animal health sector experienced a slight increase of 0.21% on October 24, with significant contributions from specific stocks, particularly Biological Shares, which led the gains [1] Market Performance - The Shanghai Composite Index closed at 3950.31, up 0.71% - The Shenzhen Component Index closed at 13289.18, up 2.02% [1] Stock Performance in Animal Health Sector - Biological Shares (600201) closed at 10.77, up 2.87% with a trading volume of 311,900 shares and a turnover of 333 million yuan - Other notable stocks include: - *ST Green Health (002868): closed at 29.09, up 0.66% - Shunlian Biological (688098): closed at 10.75, up 0.66% - Huisheng Biological (300871): closed at 20.75, up 0.48% - Yongshun Biological (920729): closed at 9.68, up 0.31% - Jinhe Biological (002688): closed at 6.68, unchanged [1] Capital Flow Analysis - The animal health sector saw a net inflow of 8.6031 million yuan from institutional investors, while retail investors experienced a net outflow of 24.4195 million yuan [2] - The breakdown of capital flow indicates: - Repu Biological (300119) had a net inflow of 9.2707 million yuan from institutional investors - Biological Shares (600201) saw a net inflow of 8.4244 million yuan - Kexin Biological (688526) had a net inflow of 5.4428 million yuan from institutional investors [3]

Group 1 - The horse racing concept sector increased by 1.40%, ranking 6th among concept sectors in terms of growth, with three stocks rising, including Zhujiang Piano and *ST Zhengping, which both hit the daily limit [1] - The main inflow of funds into the horse racing concept sector was 0.20 billion yuan, with Zhujiang Piano receiving the highest net inflow of 69.95 million yuan, followed by *ST Zhengping and Zhongmu Co., Ltd. [2][3] - The net inflow ratios for Zhujiang Piano, *ST Zhengping, and Zhongmu Co., Ltd. were 32.38%, 16.33%, and 1.25%, respectively [3] Group 2 - The top-performing concept sectors today included combustible ice with a 4.06% increase and shale gas with a 2.29% increase, while sectors like Hainan Free Trade Zone and graphite electrodes saw declines of 2.61% and 2.34%, respectively [2] - The trading volume and turnover rates for the leading stocks in the horse racing concept sector were notable, with Zhujiang Piano showing a turnover rate of 2.88% and *ST Zhengping at 1.25% [3]

Core Viewpoint - The animal health sector experienced a decline of 0.36% on October 22, with Dayu Biological leading the drop. The Shanghai Composite Index closed at 3913.76, down 0.07%, while the Shenzhen Component Index closed at 12996.61, down 0.62% [1]. Stock Performance Summary - The following stocks in the animal health sector showed varied performance: - Shengwu Co. (600201) closed at 10.78, up 0.56% with a trading volume of 327,000 shares and a turnover of 351 million yuan - Ruipu Biological (300119) closed at 21.50, up 0.51% with a trading volume of 73,200 shares and a turnover of 158 million yuan - Haili Biological (603718) closed at 7.04, up 0.28% with a trading volume of 44,200 shares and a turnover of 31.17 million yuan - Dayu Biological (920970) closed at 9.46, down 1.25% with a trading volume of 20,800 shares and a turnover of 19.89 million yuan - ST Lvkang (002868) closed at 28.49, down 1.18% with a trading volume of 9,904 shares and a turnover of 28.26 million yuan [1][2]. Capital Flow Analysis - The animal health sector saw a net outflow of 47.45 million yuan from institutional investors, while retail investors contributed a net inflow of 36.66 million yuan. Speculative funds recorded a net inflow of 10.80 million yuan [2][3]. - Specific stock capital flows included: - Shunlian Biological (688098) had a net inflow of 6.94 million yuan from institutional investors but a net outflow of 12.58 million yuan from retail investors - Ruipu Biological (300119) experienced a net outflow of 2.94 million yuan from institutional investors, with a significant net inflow of 13.74 million yuan from speculative funds [3].

Core Viewpoint - The animal health sector experienced a slight decline of 0.02% on October 21, with Bioworks leading the drop. Meanwhile, the Shanghai Composite Index rose by 1.36% and the Shenzhen Component Index increased by 2.06% [1]. Group 1: Market Performance - The animal health sector's performance was mixed, with individual stocks showing varying degrees of increase and decrease. Notably, the top gainers included: - Driving Force (4.50% increase) [1] - Dayu Biological (3.46% increase) [1] - Yongshun Biological (2.06% increase) [1] - Conversely, Bioworks saw a decline of 2.10%, leading the losses in the sector [2]. Group 2: Trading Volume and Capital Flow - The trading volume for the animal health sector indicated a net outflow of 151 million yuan from institutional investors, while retail investors saw a net inflow of 116 million yuan [2]. - The capital flow for individual stocks showed significant movements, with: - Key stock, Bioworks, experiencing a net outflow of 6.46 million yuan from institutional investors [3]. - Retail investors contributed a net inflow of 7.59 million yuan to Zhongmu Co. [3]. Group 3: Individual Stock Analysis - The following stocks had notable capital flows: - KQ Biological had a net inflow of 1.83 million yuan from institutional investors [3]. - ST Green Health faced a net outflow of 4.37 million yuan from institutional investors [3]. - The stock of Rui Pu Biological saw a net inflow of 17.22 million yuan from retail investors despite a net outflow from institutional investors [3].